“Ozempic (Semaglutide) for the Treatment of Obesity: Advantages and Disadvantages from an Integrative Analysis”. Research, Society and Development 11, no. 11 (September 4, 2022): e587111133963 . Accessed March 3, 2026. https://www.rsdjournal.org/rsd/article/view/33963.